# A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

> **NCT01270386** · PHASE2 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 136 (actual)

## Conditions studied

- Non-Small-Cell Lung Cancer

## Interventions

- **DRUG:** apatinib
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01270386
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-09
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2012-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270386, "A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01270386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*